CI Investments Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.9M | Buy |
323,880
+99,581
| +44% | +$13.1M | 0.13% | 147 |
|
|
2026
Q1 | $31.3M | Buy |
224,299
+122,233
| +120% | +$17.1M | 0.15% | 140 |
|
|
2025
Q4 | $12.5M | Sell |
102,066
-9,638
| -9% | -$1.17M | 0.05% | 201 |
|
|
2025
Q3 | $12.4M | Sell |
111,704
-53,526
| -32% | -$6.08M | 0.05% | 200 |
|
|
2025
Q2 | $18.3M | Buy |
165,230
+21,088
| +15% | +$2.24M | 0.07% | 187 |
|
|
2025
Q1 | $16.2M | Buy |
144,142
+20,317
| +16% | +$2.1M | 0.07% | 186 |
|
|
2024
Q4 | $11.4M | Buy |
123,825
+4,834
| +4% | +$435K | 0.04% | 218 |
|
|
2024
Q3 | $9.98M | Sell |
118,991
-6,534
| -5% | -$499K | 0.04% | 238 |
|
|
2024
Q2 | $8.61M | Sell |
125,525
-2,503
| -2% | -$167K | 0.03% | 225 |
|
|
2024
Q1 | $9.38M | Buy |
128,028
+28,418
| +29% | +$2.19M | 0.04% | 233 |
|
|
2023
Q4 | $8.07M | Buy |
99,610
+25,361
| +34% | +$1.97M | 0.04% | 235 |
|
|
2023
Q3 | $5.56M | Sell |
74,249
-9,579
| -11% | -$737K | 0.03% | 259 |
|
|
2023
Q2 | $6.46M | Sell |
83,828
-8,594
| -9% | -$685K | 0.03% | 252 |
|
|
2023
Q1 | $7.67M | Buy |
92,422
+43,042
| +87% | +$3.56M | 0.04% | 252 |
|
|
2022
Q4 | $4.24M | Buy |
49,380
+4,048
| +9% | +$321K | 0.02% | 286 |
|
|
2022
Q3 | $2.8M | Buy |
45,332
+194
| +0.4% | +$12.2K | 0.01% | 320 |
|
|
2022
Q2 | $2.79M | Sell |
45,138
-2,436
| -5% | -$151K | 0.01% | 320 |
|
|
2022
Q1 | $2.83M | Buy |
47,574
+12,566
| +36% | +$803K | 0.01% | 364 |
|
|
2021
Q4 | $2.54M | Buy |
35,008
+6,801
| +24% | +$468K | 0.01% | 374 |
|
|
2021
Q3 | $1.97M | Sell |
28,207
-46,856
| -62% | -$3.29M | 0.01% | 400 |
|
|
2021
Q2 | $5.17M | Sell |
75,063
-25,329
| -25% | -$1.69M | 0.02% | 345 |
|
|
2021
Q1 | $6.49M | Sell |
100,392
-282,029
| -74% | -$18.2M | 0.03% | 293 |
|
|
2020
Q4 | $22.3M | Buy |
382,421
+4,610
| +1% | +$278K | 0.1% | 180 |
|
|
2020
Q3 | $23.9M | Buy |
377,811
+30,712
| +9% | +$2.13M | 0.12% | 154 |
|
|
2020
Q2 | $26.7M | Sell |
347,099
-876,035
| -72% | -$67.1M | 0.14% | 129 |
|
|
2020
Q1 | $91.4M | Sell |
1,223,134
-4,469,319
| -79% | -$309M | 0.55% | 51 |
|
|
2019
Q4 | $370M | Sell |
5,692,453
-932,593
| -14% | -$60.7M | 1.88% | 5 |
|
|
2019
Q3 | $420M | Buy |
6,625,046
+917,751
| +16% | +$60M | 2.17% | 3 |
|
|
2019
Q2 | $387M | Buy |
5,707,295
+815,359
| +17% | +$53.6M | 2.15% | 5 |
|
|
2019
Q1 | $318M | Sell |
4,891,936
-611,943
| -11% | -$40.7M | 1.78% | 7 |
|
|
2018
Q4 | $344M | Buy |
5,503,879
+3,987,484
| +263% | +$279M | 2.22% | 2 |
|
|
2018
Q3 | $117M | Buy |
1,516,395
+282,342
| +23% | +$21.3M | 0.88% | 33 |
|
|
2018
Q2 | $87.4M | Buy |
1,234,053
+526,174
| +74% | +$37.2M | 0.69% | 47 |
|
|
2018
Q1 | $53.4M | Sell |
707,879
-1,072,613
| -60% | -$85.3M | 0.61% | 53 |
|
|
2017
Q4 | $128M | Buy |
1,780,492
+1,122,867
| +171% | +$85.3M | 1.31% | 22 |
|
|
2017
Q3 | $53.3M | Buy |
+657,625
| New | +$50.3M | 0.52% | 66 |
|
Other funds holding GILD
CI Investments Inc's GILD Position: Q2 2026 in Review
CI Investments Inc increased its Gilead Sciences (GILD) stake by 44% in Q2 2026, buying an estimated $13.1M and bringing the position to 323,880 shares worth $40.9M. The position accounts for 0.13% of the portfolio, ranked #147.
CI Investments Inc first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $420M in Q3 2019. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- CI Investments Inc held 323,880 shares of Gilead Sciences worth $40.9M as of Q2 2026.
- CI Investments Inc bought 99,581 Gilead Sciences shares in Q2 2026, an estimated $13.1M.
- Gilead Sciences made up 0.13% of CI Investments Inc's portfolio in Q2 2026, its #147 holding.
- CI Investments Inc first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- CI Investments Inc's Gilead Sciences position peaked at $420M in Q3 2019.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.